K. Teke Et Al. , "Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model," CANCER IMMUNOLOGY IMMUNOTHERAPY , no.1, pp.67-77, 2018
Teke, K. Et Al. 2018. Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model. CANCER IMMUNOLOGY IMMUNOTHERAPY , no.1 , 67-77.
Teke, K., Guzel, N., Uslubaş, A. K., Kasap, M., Yılmaz, H., Akpınar, G., ... Yildiz, D. K.(2018). Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model. CANCER IMMUNOLOGY IMMUNOTHERAPY , no.1, 67-77.
Teke, KEREM Et Al. "Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model," CANCER IMMUNOLOGY IMMUNOTHERAPY , no.1, 67-77, 2018
Teke, KEREM Et Al. "Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model." CANCER IMMUNOLOGY IMMUNOTHERAPY , no.1, pp.67-77, 2018
Teke, K. Et Al. (2018) . "Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model." CANCER IMMUNOLOGY IMMUNOTHERAPY , no.1, pp.67-77.
@article{article, author={KEREM TEKE Et Al. }, title={Monitoring the response of urothelial precancerous lesions to Bacillus Calmette-Guerin at the proteome level in an in vivo rat model}, journal={CANCER IMMUNOLOGY IMMUNOTHERAPY}, year=2018, pages={67-77} }